Yu Qian

Yu Qian

Auto-generated profile, based on publicly available information

Yu Qian

Suzhou Laboratory of Precision Health and Data Science, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Nutrition
Verified
Journal Article
Closed access
DYDing Ye
Ding Ye
XSXiaohui Sun
Xiaohui Sun
YGYing Guo
Ying Guo
KSKeding Shao
Keding Shao
YQYu Qian
Yu Qian
YMYingying Mao
Yingying Mao

28 October 2025 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
YQYu Qian
Yu Qian
JXJiangwei Xia
Jiangwei Xia
PWPingyu Wang
Pingyu Wang
CXChao Xie
Chao Xie
HLHong-Li Lin
Hong-Li Lin
HZHoufeng Zheng
Houfeng Zheng
The ultimate goal of a genome-wide association study (GWAS) is to translate its discoveries into clinical practice. To explore the clinical use of GWAS findings in the bone field, we conducted a GWAS of dual-energy X-ray absorptiometry (DXA)-derived bone mineral density (BMD) traits at 11 skeletal sites, within over 30,000 European individuals from the UK Biobank. A total of 91 unique and independent loci were identified for 11 DXA-derived BMD traits and fractures, including 5 novel loci (harboring the genes ABCA1, CHSY1, CYP24A1, SWAP70, and PAX1) for 6 BMD traits. These loci exhibited evidence of association in both males and females, which could serve as independent replication. We demonstrated that each polygenic risk score (PRS) was independently associated with fracture risk. Although incorporating multiple PRSs (i.e., metaPRS) with clinical risk factors from the Fracture Risk Assessment Tool (FRAX) yielded the highest predictive performance, the improvement was modest in fracture prediction. Additionally, we uncovered genetic correlation and shared polygenicity between head BMD and intracranial aneurysm (IA). Finally, by integrating gene expression and GWAS datasets, we prioritized genes (e.g., ESR1 and SREBF1) encoding druggable human proteins along with their respective inhibitors/antagonists. In conclusion, this comprehensive investigation reveals a new genetic basis for BMD and its clinical relevance to fracture prediction. More importantly, it suggests that head BMD is genetically correlated with IA. The prioritization of genetically supported targets implies the potential repurposing of drugs [e.g., omega-3 polyunsaturated fatty acid (PUFA) supplements] for the prevention of osteoporosis.